ZFIN Image: Zhou et al., 2019, Fig. 8

Image

Figure Caption

Fig. 8

Timo AIII attenuates the VEGF/PI3K/Akt/MAPK signaling pathway in HUVECs. a–f HUVECs were treated with various concentrations of Timo AIII (0.5, 1, and 2 µM) for 24 h. HUVECs incubated with 0.1% DMSO served as a vehicle control. Phosphorylated and total proteins were detected by Western blotting using the specific antibodies. The ratio of phosphorylated and total proteins was calculated. Data are presented as the fold of the control group. The results are presented as the means ± S.E.M. *P < 0.05, **P < 0.01, and ***P < 0.001 versus the control group

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Acta Pharmacol. Sin.